Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ONCE UPON A FARM, PBC (OFRM)

  • SEC News
  • May 06, 2026, 10:18 UTC
  • 1
  • 1 comments

(99% Neutral) ONCE UPON A FARM, PBC (OFRM) Announces Executive Changes

Comment Full text

CARTERS INC (CRI)

  • SEC News
  • May 06, 2026, 10:17 UTC
  • 1
  • 1 comments

(30% Negative) CARTERS INC (CRI) Reports Q2 2026 Financial Results

Comment Full text

VISIONWAVE HOLDINGS, INC. (VWAVW)

  • SEC News
  • May 06, 2026, 10:16 UTC
  • 1
  • 1 comments

Director VisionWave Holdings, Inc. 🟢 acquired 1538.7M shares of SaverOne 2014 Ltd. (SVRE) at $4.00 ($6154.8M) Transaction Date: Apr 28, 2026 | Filing ID: 000677

Comment Full text

ONCE UPON A FARM, PBC (OFRM)

  • SEC News
  • May 06, 2026, 10:15 UTC
  • 1
  • 1 comments

(99% Neutral) ONCE UPON A FARM, PBC (OFRM) Announces Business Combination

Comment Full text

FLOWCO HOLDINGS INC. (FLOC)

  • SEC News
  • May 06, 2026, 10:15 UTC
  • 1
  • 1 comments

(30% Negative) FLOWCO HOLDINGS INC. (FLOC) Reports Q2 2026 Financial Results

Comment Full text

GEO GROUP INC (GEO)

  • SEC News
  • May 06, 2026, 10:15 UTC
  • 0
  • 1 comments

(30% Negative) GEO GROUP INC (GEO) Reports Q2 2026 Financial Results

Comment Full text

EDGEWELL PERSONAL CARE CO (EPC)

  • SEC News
  • May 06, 2026, 10:14 UTC
  • 0
  • 1 comments

(75% Positive) EDGEWELL PERSONAL CARE CO (EPC) Reports Q2 2026 Financial Results

Comment Full text

AUDIENCE ANALYTICS LIMITED (1AZ)

  • SEC News
  • May 06, 2026, 10:12 UTC
  • 0
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes of Interest of Director - Ooi Keim Fung

Comment Full text

AMCOR PLC (AMCR)

  • SEC News
  • May 06, 2026, 10:12 UTC
  • 0
  • 1 comments

(99% Neutral) AMCOR PLC (AMCR) Reports Q2 2026 Financial Results

Comment Full text

AUDIENCE ANALYTICS LIMITED (1AZ)

  • SEC News
  • May 06, 2026, 10:11 UTC
  • 0
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes of Interest of Director - Ng Yan Meng

Comment Full text
  • Previous
  • 251
  • 252
  • 253
  • 254
  • 255
  • Next

Search

News categories

  • Technical Exchange News(12342)
  • Event(6229)
  • SEC News(270218)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157471)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin